Literature DB >> 15004083

Preferential presence of decorin-binding protein B (BBA25) and BBA50 antibodies in cerebrospinal fluid of patients with neurologic Lyme disease.

Erol Fikrig1, Patricia K Coyle, Steven E Schutzer, Manchuan Chen, Zhidian Deng, Richard A Flavell.   

Abstract

Borrelia burgdorferi antibodies preferentially present in cerebrospinal fluid (CSF) were examined by differentially probing a B. burgdorferi expression library with CSF and sera from patients with neurologic Lyme disease. Several phage clones selectively reacted with CSF, and these genes were then expressed in recombinant form and used to detect specific antibody in an enzyme-linked immunosorbent assay. Decorin-binding protein B (BBA25) and BBA50 (hypothetical protein) elicited immunoglobulin G (IgG) or IgM detectable in CSF-but not sera-of patients, demonstrating preferential antibody production during neuroborreliosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004083      PMCID: PMC356844          DOI: 10.1128/JCM.42.3.1243-1246.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Serodiagnosis of neuroborreliosis: comparison of reliability of three confirmatory assays.

Authors:  R Kaiser; S Rauer
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

Review 2.  Arthropod- and host-specific gene expression by Borrelia burgdorferi.

Authors:  A M de Silva; E Fikrig
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

3.  Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosis.

Authors:  K E Hagman; P Lahdenne; T G Popova; S F Porcella; D R Akins; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Borrelia burgdorferi-specific immune complexes in acute Lyme disease.

Authors:  S E Schutzer; P K Coyle; P Reid; B Holland
Journal:  JAMA       Date:  1999-11-24       Impact factor: 56.272

5.  Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission.

Authors:  E Fikrig; W Feng; S W Barthold; S R Telford; R A Flavell
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

6.  Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens.

Authors:  L A Magnarelli; J W Ijdo; S J Padula; R A Flavell; E Fikrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

7.  Decorin-binding protein A (DbpA) of Borrelia burgdorferi is not protective when immunized mice are challenged via tick infestation and correlates with the lack of DbpA expression by B. burgdorferi in ticks.

Authors:  K E Hagman; X Yang; S K Wikel; G B Schoeler; M J Caimano; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

8.  Borrelia burgdorferi erpT expression in the arthropod vector and murine host.

Authors:  E Fikrig; M Chen; S W Barthold; J Anguita; W Feng; S R Telford; R A Flavell
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

9.  Analysis of the intrathecal immune response in neuroborreliosis to a sonicate antigen and three recombinant antigens of Borrelia burgdorferi sensu stricto.

Authors:  R Kaiser; S Rauer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

10.  Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.

Authors:  A M de Silva; S R Telford; L R Brunet; S W Barthold; E Fikrig
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  7 in total

1.  Global Tn-seq analysis of carbohydrate utilization and vertebrate infectivity of Borrelia burgdorferi.

Authors:  Erin B Troy; Tao Lin; Lihui Gao; David W Lazinski; Maureen Lundt; Andrew Camilli; Steven J Norris; Linden T Hu
Journal:  Mol Microbiol       Date:  2016-07-15       Impact factor: 3.501

2.  Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier.

Authors:  Dennis J Grab; George Perides; J Stephen Dumler; Kee Jun Kim; Jinho Park; Yuri V Kim; Olga Nikolskaia; Kyoung Seong Choi; Monique F Stins; Kwang Sik Kim
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

3.  EbfC (YbaB) is a new type of bacterial nucleoid-associated protein and a global regulator of gene expression in the Lyme disease spirochete.

Authors:  Brandon L Jutras; Amy Bowman; Catherine A Brissette; Claire A Adams; Ashutosh Verma; Alicia M Chenail; Brian Stevenson
Journal:  J Bacteriol       Date:  2012-04-27       Impact factor: 3.490

4.  Global transcriptome analysis of Borrelia burgdorferi during association with human neuroglial cells.

Authors:  Jill A Livengood; Virginia L Schmit; Robert D Gilmore
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

5.  Genotypic variation and mixtures of Lyme Borrelia in Ixodes ticks from North America and Europe.

Authors:  Chris D Crowder; Heather E Matthews; Steven Schutzer; Megan A Rounds; Benjamin J Luft; Oliver Nolte; Scott R Campbell; Curtis A Phillipson; Feng Li; Ranga Sampath; David J Ecker; Mark W Eshoo
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

6.  OspA-CD40 dyad: ligand-receptor interaction in the translocation of neuroinvasive Borrelia across the blood-brain barrier.

Authors:  Lucia Pulzova; Andrej Kovac; Rastislav Mucha; Patrik Mlynarcik; Elena Bencurova; Marian Madar; Michal Novak; Mangesh Bhide
Journal:  Sci Rep       Date:  2011-09-08       Impact factor: 4.379

7.  Transcriptomic insights on the virulence-controlling CsrA, BadR, RpoN, and RpoS regulatory networks in the Lyme disease spirochete.

Authors:  William K Arnold; Christina R Savage; Kathryn G Lethbridge; Trever C Smith; Catherine A Brissette; Janakiram Seshu; Brian Stevenson
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.